Literature DB >> 26603138

Neurogenic effect of VEGF is related to increase of astrocytes transdifferentiation into new mature neurons in rat brains after stroke.

Shu-Wen Shen1, Chun-Ling Duan1, Xian-Hua Chen1, Yong-Quan Wang1, Xiao Sun1, Qiu-Wan Zhang1, Hui-Ru Cui1, Feng-Yan Sun2.   

Abstract

To study the cellular mechanism of vascular endothelial growth factor (VEGF)-enhanced neurogenesis in ischemic brain injury, we used middle cerebral artery occlusion (MCAO) model to induce transient focal ischemic brain injury. The results showed that ischemic injury significantly increased glial fibrillary acidic protein immunopositive (GFAP(+)) and nestin(+) cells in ipsilateral striatum 3 days following MCAO. Most GFAP(+) cells colocalized with nestin (GFAP(+)-nestin(+)), Pax6 (GFAP(+)-Pax6(+)), or Olig2 (GFAP(+)-Olig2(+)). VEGF further increased GFAP(+)-nestin(+) and GFAP(+)-Pax6(+) cells, and decreased GFAP(+)-Olig2(+) cells. We used striatal injection of GFAP targeted enhanced green fluorescence protein (pGfa2-EGFP) vectors combined with multiple immunofluorescent staining to trace the neural fates of EGFP-expressing (GFP(+)) reactive astrocytes. The results showed that MCAO-induced striatal reactive astrocytes differentiated into neural stem cells (GFP(+)-nestin(+) cells) at 3 days after MCAO, immature (GFP(+)-Tuj-1(+) cells) at 1 week and mature neurons (GFP(+)-MAP-2(+) or GFP(+)-NeuN(+) cells) at 2 weeks. VEGF increased GFP(+)-NeuN(+) and BrdU(+)-MAP-2(+) newborn neurons after MCAO. Fluorocitrate, an astrocytic inhibitor, significantly decreased GFAP and nestin expression in ischemic brains, and also reduced VEGF-enhanced neurogenic effects. This study is the first time to report that VEGF-mediated increase of newly generated neurons is dependent on the presence of reactive astrocytes. The results also illustrate cellular mechanism of VEGF-enhanced neural repair and functional plasticity in the brains after ischemic injury. We concluded that neurogenic effect of VEGF is related to increase of striatal astrocytes transdifferentiation into new mature neurons, which should be very important for the reconstruction of neurovascular units/networks in non-neurogenic regions of the mammalian brain.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astroglial; Neural network; Neurogenesis; Neurovascular unit; Stroke

Mesh:

Substances:

Year:  2015        PMID: 26603138     DOI: 10.1016/j.neuropharm.2015.11.012

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  18 in total

1.  Balanced single-vector co-delivery of VEGF/PDGF-BB improves functional collateralization in chronic cerebral ischemia.

Authors:  Aiki Marushima; Melina Nieminen; Irina Kremenetskaia; Roberto Gianni-Barrera; Johannes Woitzik; Georges von Degenfeld; Andrea Banfi; Peter Vajkoczy; Nils Hecht
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-09       Impact factor: 6.200

Review 2.  Post-stroke remodeling processes in animal models and humans.

Authors:  Carla Cirillo; Nabila Brihmat; Evelyne Castel-Lacanal; Alice Le Friec; Marianne Barbieux-Guillot; Nicolas Raposo; Jérémie Pariente; Alain Viguier; Marion Simonetta-Moreau; Jean-François Albucher; Jean-Marc Olivot; Franck Desmoulin; Philippe Marque; François Chollet; Isabelle Loubinoux
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-23       Impact factor: 6.200

Review 3.  Pharmacological approaches promoting stem cell-based therapy following ischemic stroke insults.

Authors:  Shu-Zhen Zhu; Vivian Szeto; Mei-Hua Bao; Hong-Shuo Sun; Zhong-Ping Feng
Journal:  Acta Pharmacol Sin       Date:  2018-04-19       Impact factor: 6.150

Review 4.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

5.  Fingolimod phosphate inhibits astrocyte inflammatory activity in mucolipidosis IV.

Authors:  Laura D Weinstock; Amanda M Furness; Shawn S Herron; Sierra S Smith; Sitara B Sankar; Samantha G DeRosa; Dadi Gao; Molly E Mepyans; Anna Scotto Rosato; Diego L Medina; Ayelet Vardi; Natalia S Ferreira; Soo Min Cho; Anthony H Futerman; Susan A Slaugenhaupt; Levi B Wood; Yulia Grishchuk
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

6.  Effect of the Recombinant Adenovirus-Mediated HIF-1 Alpha on the Expression of VEGF in the Hypoxic Brain Microvascular Endothelial Cells of Rats.

Authors:  Ming-Lu Jin; Zhe-Hua Zou; Tao Tao; Jun Li; Jian Xu; Kai-Jian Luo; Zhi Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-07       Impact factor: 2.570

7.  Disabling VEGF-Response of Purkinje Cells by Downregulation of KDR via miRNA-204-5p.

Authors:  Julian Gehmeyr; Abdelouahid Maghnouj; Jonas Tjaden; Matthias Vorgerd; Stephan Hahn; Veronika Matschke; Verena Theis; Carsten Theiss
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

8.  VEGF Axonal Transport Dependent on Kinesin-1B and Microtubules Dynamics.

Authors:  Ping Yang; Xiao Sun; Zeng-Wei Kou; Kun-Wei Wu; Ya-Lin Huang; Feng-Yan Sun
Journal:  Front Mol Neurosci       Date:  2017-12-21       Impact factor: 5.639

Review 9.  The Role of Astrocytes in Neuroprotection after Brain Stroke: Potential in Cell Therapy.

Authors:  Andrea Becerra-Calixto; Gloria P Cardona-Gómez
Journal:  Front Mol Neurosci       Date:  2017-04-03       Impact factor: 5.639

10.  The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.

Authors:  Petra I Lorenzo; Eugenia Martin Vazquez; Livia López-Noriega; Esther Fuente-Martín; José M Mellado-Gil; Jaime M Franco; Nadia Cobo-Vuilleumier; José A Guerrero Martínez; Silvana Y Romero-Zerbo; Jesús A Perez-Cabello; Sabrina Rivero Canalejo; Antonio Campos-Caro; Christian Claude Lachaud; Alejandra Crespo Barreda; Manuel Aguilar-Diosdado; Eduardo García Fuentes; Alejandro Martin-Montalvo; Manuel Álvarez Dolado; Franz Martin; Gemma Rojo-Martinez; David Pozo; Francisco J Bérmudez-Silva; Valentine Comaills; José C Reyes; Benoit R Gauthier
Journal:  Theranostics       Date:  2021-05-12       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.